Sign In
Buy AXGN
$40.63
+1.17 (+2.97%)
At Close: Jun 03, 2026
Axogen, Inc. (AXGN) Q2 2025 Earnings Call Transcript
01:15pm, Tuesday, 05'th Aug 2025
Axogen, Inc. (NASDAQ:AXGN ) Q2 2025 Earnings Conference Call August 5, 2025 8:00 AM ET Company Participants Jens Schroeder Kemp - Chief Marketing Officer Lindsey Hartley - Chief Financial Officer Mich
AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates
09:16am, Tuesday, 05'th Aug 2025
AxoGen (AXGN) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.05 per share a year ago.
Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference
04:10pm, Tuesday, 29'th Jul 2025
ALACHUA, Fla. and TAMPA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of periphera
AxoGen (AXGN) Earnings Expected to Grow: Should You Buy?
11:05am, Tuesday, 29'th Jul 2025
AxoGen (AXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025
04:05pm, Tuesday, 22'nd Jul 2025
ALACHUA, Fla. and TAMPA, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of periphera
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference
08:00am, Wednesday, 28'th May 2025
ALACHUA, Fla. and TAMPA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, to
AxoGen (AXGN) Loses 25.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
10:36am, Wednesday, 21'st May 2025
The heavy selling pressure might have exhausted for AxoGen (AXGN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in
AxoGen (AXGN) Reports Q1 Loss, Tops Revenue Estimates
09:30am, Thursday, 08'th May 2025
AxoGen (AXGN) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to loss of $0.06 per share a year ago.
Axogen, Inc. Reports 2025 First Quarter Financial Results
07:05am, Thursday, 08'th May 2025
ALACHUA, Fla. and TAMPA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, to
Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025
08:04am, Thursday, 24'th Apr 2025
ALACHUA and TAMPA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today
Axogen, Inc. (AXGN) Q4 2024 Earnings Call Transcript
01:58pm, Tuesday, 25'th Feb 2025
Axogen, Inc. (NASDAQ:AXGN ) Q4 2024 Earnings Conference Call February 25, 2025 8:00 AM ET Company Participants Michael Dale - Chairman and Chief Executive Officer Nir Naor - Chief Financial Officer Je
Axogen, Inc. To Host Analyst & Investor Day on March 4th
07:10am, Tuesday, 25'th Feb 2025
ALACHUA, Fla. and TAMPA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, w
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025
04:58pm, Tuesday, 11'th Feb 2025
ALACHUA, Fla. and TAMPA, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, t
AxoGen, Inc. (AXGN) Soars to 52-Week High, Time to Cash Out?
10:36am, Monday, 13'th Jan 2025
AxoGen (AXGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
AxoGen (AXGN) Moves 18.2% Higher: Will This Strength Last?
06:11am, Monday, 13'th Jan 2025
AxoGen (AXGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
